Carmel B. Nanthakumar

1.6k total citations · 1 hit paper
15 papers, 932 citations indexed

About

Carmel B. Nanthakumar is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Carmel B. Nanthakumar has authored 15 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Molecular Biology. Recurrent topics in Carmel B. Nanthakumar's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Occupational exposure and asthma (3 papers). Carmel B. Nanthakumar is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Occupational exposure and asthma (3 papers). Carmel B. Nanthakumar collaborates with scholars based in United Kingdom, Denmark and United States. Carmel B. Nanthakumar's co-authors include Richard P. Marshall, Gísli Jenkins, Richard J. D. Hatley, Simon J. F. Macdonald, Jack Gauldie, Rachel C. Chambers, Geoffrey J. Laurent, Robin J. McAnulty, Amanda L. Tatler and Andy Blanchard and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Reviews Drug Discovery and American Journal Of Pathology.

In The Last Decade

Carmel B. Nanthakumar

14 papers receiving 923 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

2017 280 citations Gísli Jenkins, Bethany B. Moore et al. American Journal of Respiratory Cell and Molecular Biology profile →

Peers

Carmel B. Nanthakumar

PRM

SURGE

PHYSI

ONCOL

Evelina Fagone Italy

Katharina Heinzelmann Germany

Edilson Torres-González United States

Toshiyuki Sumi Japan

Gavin Tjin Australia

Katharine E. Black United States

Roxana Wasnick United States

Anusha Sridharan United States

Amber L. Degryse United States

Giannoula Soufla Greece

Evelina Fagone Italy

Carmel B. Nanthakumar

606 ×1.0

PRM

251 ×1.1

71 ×0.7

SURGE

149 ×1.6

PHYSI

91 ×1.1

ONCOL

Citations per year, relative to Carmel B. Nanthakumar Carmel B. Nanthakumar (= 1×) peers Evelina Fagone

Countries citing papers authored by Carmel B. Nanthakumar

Since Specialization

Citations

This map shows the geographic impact of Carmel B. Nanthakumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmel B. Nanthakumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmel B. Nanthakumar more than expected).

Fields of papers citing papers by Carmel B. Nanthakumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmel B. Nanthakumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmel B. Nanthakumar. The network helps show where Carmel B. Nanthakumar may publish in the future.

Co-authorship network of co-authors of Carmel B. Nanthakumar

This figure shows the co-authorship network connecting the top 25 collaborators of Carmel B. Nanthakumar. A scholar is included among the top collaborators of Carmel B. Nanthakumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmel B. Nanthakumar. Carmel B. Nanthakumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Karsdal, M.A., Diana Julie Leeming, Carmel B. Nanthakumar, et al.. (2025). Comorbidity profiles in chronic obstructive pulmonary disease: a multicohort study. ERJ Open Research. 11(5). 1289–2024.

Wang, Zejing, et al.. (2021). Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors. Amino Acids. 53(2). 205–217. 25 indexed citations

Khan, Muzamil Majid, Daniel Poeckel, Aliaksandr Halavatyi, et al.. (2020). An integrated multiomic and quantitative label-free microscopy-based approach to study pro-fibrotic signalling in ex vivo human precision-cut lung slices. European Respiratory Journal. 58(1). 2000221–2000221. 25 indexed citations

Rønnow, Sarah Rank, Federica Genovese, Carmel B. Nanthakumar, et al.. (2020). Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis. Respiratory Research. 21(1). 108–108. 29 indexed citations

Organ, Louise, Eunice Oballa, Juliet K. Simpson, et al.. (2019). Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort. Respiratory Research. 20(1). 148–148. 88 indexed citations

Good, Robert B., Radu Rapiteanu, Tobias Schmidt, et al.. (2019). Single-Step, High-Efficiency CRISPR-Cas9 Genome Editing in Primary Human Disease-Derived Fibroblasts. The CRISPR Journal. 2(1). 31–40. 18 indexed citations

Good, Robert B., Jessica Eley, Elaine Gower, et al.. (2019). A high content, phenotypic ‘scar-in-a-jar’ assay for rapid quantification of collagen fibrillogenesis using disease-derived pulmonary fibroblasts. SHILAP Revista de lepidopterología. 1(1). 14–14. 20 indexed citations

Nanthakumar, Carmel B., Jessica Eley, Yim Man, et al.. (2019). Omipalasib Modulates Extracellular Matrix Turnover in IPF Patients: Exploratory Biomarker Analysis from a Phase I Proof of Mechanism Study. A7301–A7301. 5 indexed citations

Jenkins, Gísli, Bethany B. Moore, Rachel C. Chambers, et al.. (2017). An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 56(5). 667–679. 280 indexed citations breakdown →

10.

Mercer, Paul F., Hannah V. Woodcock, Jessica Eley, et al.. (2016). Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF. Thorax. 71(8). 701–711. 154 indexed citations

11.

Gower, Elaine, et al.. (2016). P109 <break /> High Affinity Engagement of the αvβ6 Integrin Induces Degradation: A Novel Mechanism for Sustained Inhibition of Pro-Fibrotic TGFβ Activation.. QJM. 2 indexed citations

12.

Nanthakumar, Carmel B., et al.. (2015). Dissecting fibrosis: therapeutic insights from the small-molecule toolbox. Nature Reviews Drug Discovery. 14(10). 693–720. 173 indexed citations

13.

Woodcock, Hannah V., et al.. (2015). mTOR signalling is an essential pathway for TGF-β₁induced collagen synthesis. PA935–PA935. 3 indexed citations

14.

Woodcock, Hannah V., Simon Peace, Carmel B. Nanthakumar, et al.. (2014). S136 Mtor Signalling Is An Essential Pathway For Tgf- 1 Induced sma And Collagen Gene Expression. Thorax. 69(Suppl 2). A73–A73. 2 indexed citations

15.

Jenkins, Gísli, Caroline Wheeler‐Jones, Stephen E. Bottoms, et al.. (2004). Severity of Lung Injury in Cyclooxygenase-2-Deficient Mice Is Dependent on Reduced Prostaglandin E2 Production. American Journal Of Pathology. 165(5). 1663–1676. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact